|
|
|
|
|
|||||||
| Stock Trading Discussion board for stock traders. |
 |
| Bookmarks | |||||||
del.icio.us
|
StumbleUpon
|
Google
|
Digg
|
Facebook
|
Furl
|
Reddit
|
Netscape
|
|
|
LinkBack (1) | Thread Tools | Search this Thread | Display Modes | Language |
01-07-2008, 04:32 PM
|
||||
|
||||
|
Isis
ISIS Pharmaceuticals just signed a deal which is expected to skyrocket.
Genzyme and Isis inked a deal where Genzyme would buy $5M shares at $30 a share, and Genzyme will pay Isis $350M in licensing fees. Isis will also receive up to $750M in commercial milestone payments and $825M in development. As per the deal, the profit will split 70/30 for Genzyme/Isis until the $2B mark is met and then each company will get 50% of the profits. The drug is called Mipomersen and it is a cholesterol reduction drug. This is expected to 
|
|
01-07-2008, 11:03 PM
|
||||
|
||||
|
Re: Isis
|
|
01-08-2008, 09:55 AM
|
|||||||||||||||
|
|||||||||||||||
|
Re: Isis
The price is up to $19 this morning. Wachovia said this stock valuation will go to $30-$34 and another firm upped the target price from $20 to $26.
|
|||||||||||||||
|
LinkBacks (?)
LinkBack to this Thread: http://www.traderslaboratory.com/forums/f25/isis-3176.html
|
|||
| Posted By | For | Type | Date |
| Traders Laboratory | This thread | Refback | 01-07-2008 04:42 PM |
| Currently Active Users Viewing This Thread: 1 (0 members and 1 guests) | |
| Thread Tools | Search this Thread |
| Display Modes | |
|
|
Linear Mode
